The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
内质网应激诱导的硒蛋白 SelenoS 可调节蛋白质稳态和心脏肥大
基本信息
- 批准号:10322459
- 负责人:
- 金额:$ 42.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:ATF6 geneAddressAffectAntioxidantsCalciumCardiacCardiac MyocytesCardiovascular DiseasesCardiovascular systemCell modelCellsCessation of lifeComplexDietEctopic ExpressionElementsEndoplasmic ReticulumEndoplasmic Reticulum Degradation PathwayEnsureEquilibriumExerciseGene ExpressionGoalsGrowthHeartHeart ContractilitiesHeart DiseasesHeart HypertrophyHeart failureHypertrophyIGF1 geneImpairmentInvestigationKnowledgeLeadLifeMediatingModelingMolecularMolecular GeneticsMusMuscle CellsMutateNeonatalNodalOrganPathologicPhenylephrinePhysiologicalPlayProcessProtein BiosynthesisProteinsProteomeRattusRegulationRodentRoleSeleniumSiteStimulusStructureTimeTranscriptVentricularWorkbasecardiovascular healthendoplasmic reticulum stressgenetic approachheart functionheart preservationin vivoinnovationknock-downmisfolded proteinmortalitymouse modelmutantoverexpressionpressureprotein degradationprotein expressionprotein foldingproteostasisreceptorrecruitselenoproteinsensortranscription factor
项目摘要
Project Summary
Many forms of cardiovascular disease lead to pathological cardiac hypertrophy, which is maladaptive because
it causes reduced contractility of the heart, resulting in life-threatening heart failure. In contrast, exercise can
cause the heart to grow in a functionally adaptive way; this is defined as physiological cardiac hypertrophy. Our
long-term goal is to achieve a better mechanistic understanding of both forms of heart growth. In this proposal,
we will address this understanding by examining roles for selenium (Se) in cardiac hypertrophy. Se, which is
an essential element in our diet, is well known to be required for cardiovascular health, though the precise role
played by Se the cardiovascular system is not known. A major role for Se in all organs and cells is that it is a
key component of selenoproteins; here, we will examine the function of Se in selenoproteins in the heart. Our
specific objective is to examine the selenoprotein, SelenoS, which we believe to be required for both
pathological and physiological cardiac hypertrophy. We will conduct this investigation in mouse models of
cardiac hypertrophy using molecular genetic approaches to selectively and specifically impair or enhance the
function of SelenoS, followed by studies to determine the effects of these maneuvers on heart structure and
function. One mechanistic point we will be addressing is how Se affects heart growth. However, since there are
23 other proteins in mice that require Se, in order to focus our approach on determining how Se is used by only
SelenoS in the heart, we will examine the effects of a mutant form of SelenoS, SelenoS-Se, which is different
from SelenoS only in that it does not have Se. In this way, we will be able to mechanistically pinpoint how Se
on just SelenoS works to support cardiac growth, because all of the other selenoproteins will still have Se
incorporated into their structures. SelenoS is also involved in the adaptive degradation of misfolded proteins in
the endoplasmic reticulum, a process called ERAD. We will also examine the effects of SelenoS, SelenoS-Se,
and a form of SelenoS that cannot function in ERAD, Seleno-ERAD, on cardiac growth. Our specific aims are
to 1- determine the effects of depleting endogenous SelenoS on cardiac structure, function, gene and protein
expression in mouse models of cardiac hypertrophy, 2- examine the effects of ectopic expression of SelenoS,
Seleno-ERAD and SelenoS-Se in mice in which endogenous SelenoS has been knocked down on pathological
and physiological cardiac hypertrophy, and 3- assess how SelenoS, Seleno-ERAD and SelenoS-Se affect the
structure and function of the ERAD complex.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chris Glembotski其他文献
Chris Glembotski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chris Glembotski', 18)}}的其他基金
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
非典型 ERAD 作为心脏肥大的调节剂
- 批准号:
10544178 - 财政年份:2022
- 资助金额:
$ 42.67万 - 项目类别:
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
非典型 ERAD 作为心脏肥大的调节剂
- 批准号:
10817347 - 财政年份:2022
- 资助金额:
$ 42.67万 - 项目类别:
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
非典型 ERAD 作为心脏肥大的调节剂
- 批准号:
10363838 - 财政年份:2022
- 资助金额:
$ 42.67万 - 项目类别:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
内质网应激诱导的硒蛋白 SelenoS 可调节蛋白质稳态和心脏肥大
- 批准号:
10550149 - 财政年份:2020
- 资助金额:
$ 42.67万 - 项目类别:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
利用适应性 ER 应激反应治疗心肌缺血
- 批准号:
10227351 - 财政年份:2020
- 资助金额:
$ 42.67万 - 项目类别:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
内质网应激诱导的硒蛋白 SelenoS 可调节蛋白质稳态和心脏肥大
- 批准号:
10218914 - 财政年份:2020
- 资助金额:
$ 42.67万 - 项目类别:
ATF6 is Required for ANP Secretion from the Heart
ATF6 是心脏分泌 ANP 所必需的
- 批准号:
10219762 - 财政年份:2018
- 资助金额:
$ 42.67万 - 项目类别:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
利用适应性 ER 应激反应治疗心肌缺血
- 批准号:
9389978 - 财政年份:2017
- 资助金额:
$ 42.67万 - 项目类别:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
利用适应性 ER 应激反应治疗心肌缺血
- 批准号:
9924642 - 财政年份:2017
- 资助金额:
$ 42.67万 - 项目类别:
Role of the SR/ER E3 Ubiquitin Ligase Synoviolin 1 in Cardiac Hypertrophy
SR/ER E3 泛素连接酶 Synoviolin 1 在心脏肥大中的作用
- 批准号:
9102175 - 财政年份:2015
- 资助金额:
$ 42.67万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 42.67万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 42.67万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 42.67万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 42.67万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 42.67万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 42.67万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 42.67万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 42.67万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 42.67万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 42.67万 - 项目类别:
Research Grant














{{item.name}}会员




